Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,089
Total Claims
$700K
Drug Cost
497
Beneficiaries
$1,408
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+29%
Opioid rate vs peers
2.9% vs 2.2% avg
0%
Cost per patient vs peers
$1,408 vs $1,411 avg
+13%
Brand preference vs peers
12.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.9%
Opioid Rate
263
Opioid Claims
$7,680
Opioid Cost
8.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,082 claims · $521K
Generic: 7,888 claims · $172K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 202 | $163K |
| Linagliptin | 37 | $35K |
| Mirabegron | 52 | $30K |
| Alirocumab | 46 | $26K |
| Dulaglutide | 16 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 42 | $19K |
| Rivaroxaban | 19 | $14K |
| Insulin Lispro | 20 | $14K |
| Insulin Degludec | 12 | $12K |
| Tirzepatide | 11 | $12K |
| Budesonide/Formoterol Fumarate | 17 | $12K |
| Fluticasone/Umeclidin/Vilanter | 14 | $11K |
| Memantine Hcl | 139 | $10K |
| Lipase/Protease/Amylase | 11 | $7,983 |
| Atorvastatin Calcium | 629 | $7,345 |
Prescribing Profile
Patient Profile
79
Avg Age
68%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About